Related Experiment Video

Updated: May 27, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Individualizing follow-up for patients with early-stage melanoma

Vernon K Sondak, Sancy A Leachman

    Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
    |November 10, 2011
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
    07:41

    A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

    Published on: March 8, 2022

    Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma
    12:16

    Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma

    Published on: March 13, 2013

    Related Experiment Videos

    Last Updated: May 27, 2026

    A 3D Organotypic Melanoma Spheroid Skin Model
    08:49

    A 3D Organotypic Melanoma Spheroid Skin Model

    Published on: May 18, 2018

    A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
    07:41

    A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

    Published on: March 8, 2022

    Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma
    12:16

    Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma

    Published on: March 13, 2013

    Related Concept Videos

    Skin Cancer01:30

    Skin Cancer

    Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
    Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

    Articles linked to this work by shared authors, journal, and citation graph.

    Therapy-Associated Vitiligo: Hypopigmentation Secondary to Programmed Cell Death Protein 1 Inhibitors, Interferon Alfa-2b, Cytotoxic T-Lymphocyte-Associated Protein 4 Inhibitors, and B-Raf/Mitogen-Activated Protein Kinase Kinase Inhibitors.

    Cureus·2026

    Cost-Effectiveness of Vaccine for the Prevention of Herpes Zoster in Kidney Transplant Recipients in Thailand.

    Value in health regional issues·2026

    The response of human melanocytic nevi to simulated solar radiation assessed by single-nucleus RNA sequencing of frozen tissue.

    The Journal of investigative dermatology·2026

    Thin and in situ melanoma: an update for the dermatologist.

    Anais brasileiros de dermatologia·2026

    Correction: Oregon primary care providers as a frontline defense in the War on Melanoma™: improving access to melanoma education.

    Frontiers in medicine·2026

    Quantitative versus qualitative risk framing in patient decision aids for dysplastic nevi: A randomized A/B testing study.

    Journal of the American Academy of Dermatology·2026

    Perioperative Durvalumab for Resectable Non-Small Cell Lung Cancer: Updated Outcomes From the Phase III AEGEAN Trial.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Long-Term Survival Outcomes of Modified-FOLFOXIRI Plus Cetuximab Versus Bevacizumab in RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Analysis of the DEEPER Trial.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Refined Continuous Risk Index for Accurately Predicting Outcomes of Patients With Chronic Lymphocytic Leukemia After Limited-Duration Therapy.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Medical Therapy for Hormone Receptor-Positive, HER2-Negative Stage I-III Breast Cancer: ASCO Living Guideline, Version 2026.1.0.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: A Phase III Randomized Clinical Trial.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    The Patient Who Could Not Die.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Quantitative Apparent Diffusion Coefficient (ADC) Mapping as a Preoperative Biomarker for Tumor Grade and Myometrial Invasion in Endometrial Carcinoma.

    Annals of African medicine·2026

    Assessment of Phenotype, Oxidative Stress and Biomacromolecule Oxidation in Human Chronic Skin Wound Epidermis in Active Debridement Tissue Versus Endstage Wounds.

    Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society·2026

    Clinical Significance, Immune Infiltration Landscape, and Functional Network Analysis of miR-192-5p in Colorectal Cancer.

    Journal of visualized experiments : JoVE·2026

    Non-parametric differential methylation analysis characterizes histotype-specific promoter regions in epithelial ovarian cancer.

    Epigenetics·2026

    Residential location shapes initial prostate cancer care in Korea (2010-2020): A nationwide stage- and risk-stratified study.

    Investigative and clinical urology·2026

    Predictors of active surveillance discontinuation in prostate cancer: Large Korean multicenter cohort study.

    Investigative and clinical urology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us